Immediate Impact
1 by Nobel laureates 1 from Science/Nature 68 standout
Citing Papers
The scope of the antimicrobial resistance challenge
2024 Standout
Deuterium in drug discovery: progress, opportunities and challenges
2023 Standout
Works of Stephen Flach being referenced
Pharmacokinetics, Safety, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor for Hepatitis C Virus, following Single Ascending Doses in Healthy Subjects
2012
Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Stephen Flach | 50 | 146 | 102 | 56 | 35 | 465 | |
| Kimberly Ward | 10 | 237 | 172 | 52 | 37 | 560 | |
| Oralia V. Bazaldua | 68 | 131 | 97 | 87 | 20 | 535 | |
| Wondimeneh Shibabaw Shiferaw | 35 | 51 | 109 | 17 | 50 | 563 | |
| Sharon B. Meropol | 23 | 89 | 145 | 23 | 24 | 522 | |
| Xavier Roux | 20 | 37 | 208 | 18 | 21 | 453 | |
| Heti Pisarev | 18 | 48 | 116 | 33 | 38 | 536 | |
| Alan C. Kinlaw | 13 | 77 | 126 | 57 | 61 | 483 | |
| Jody A. Vogel | 89 | 94 | 60 | 28 | 44 | 533 | |
| Hyun Soon Sohn | 68 | 43 | 87 | 75 | 59 | 483 | |
| Mark Lambert | 33 | 166 | 50 | 58 | 30 | 432 |
All Works
Loading papers...